We monitor analyst coverage, shareholder behavior, and peer activity to advise clients on perception risks, emerging opportunities, and competitive positioning.
Whether you're a groundbreaking startup or an established industry leader, we're ready to amplify your vision — together.
Contact Us
NPR
March 18, 2026
On this week’s BioTech Nation, Moira speaks with Dr. Adam Rogers, CEO of NervGen Pharma, about a new treatment that’s...
For more
The Scientist
February 7, 2026
Nobel Prize winner Shimon Sakaguchi, a pioneer in regulatory T cell (Treg) biology, discusses the path from early observations to...
For more
WGN-TV
February 5, 2026
There is a new hope for people with spinal cord injuries. Doctors are using an experimental, easy to deliver drug,...
For more
Russo Partners LLC
(212) 845-4200
215 Park Ave SOUTH, Suite 1905
New York, NY 10003
© 2026 Russo Partners LLC. All rights reserved.